亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses.

核糖核酸 病毒 RNA干扰 严重急性呼吸综合征冠状病毒 倍他科诺病毒 生物 小干扰RNA 冠状病毒感染
作者
Muhammad Imran Sajid,Muhammad Moazzam,Yeseom Cho,Shun Kato,Ava Xu,J. J. Way,Sandeep Lohan,Rakesh Tiwari
出处
期刊:Molecular Pharmaceutics [American Chemical Society]
卷期号:18 (6): 2105-2121 被引量:5
标识
DOI:10.1021/acs.molpharmaceut.0c01239
摘要

The ongoing pandemic of global concern has killed about three million humans and affected around 151 million people worldwide, as of April 30, 2021. Although recently approved vaccines for COVID-19 are engendering hope, finding new ways to cure the viral pandemic is still a quest for researchers worldwide. Major pandemics in history have been of viral origin, such as SARS, MERS, H1NI, Spanish flu, and so on. A larger emphasis has been on discovering potential vaccines, novel antiviral drugs, and agents that can mitigate the viral infection symptoms; however, a relatively new area, RNA interference (RNAi), has proven effective as an antiviral agent. The RNAi phenomenon has been largely exploited to cure cancer, neurodegenerative diseases, and some rare diseases. The U.S. Food and Drug Administration has recently approved three siRNA products for human use that garner significant hope in siRNA therapeutics for coronaviruses. There have been some commentaries and communications addressing this area. We have summarized and illustrated the significance and the potential of the siRNA therapeutics available as of April 30, 2021 to combat the ongoing viral pandemic and the emerging new variants such as B.1.1.7 and B.1.351. Numerous successful in vitro studies and several investigations to address the clinical application of siRNA therapeutics provide great hope in this field. This seminal Review describes the significance of siRNA-based therapy to treat diverse viral infections in addition to the current coronavirus challenge. In addition, we have thoroughly reviewed the patents approved for coronaviruses, the major challenges in siRNA therapy, and the potential approaches to address them, followed by innovation and prospects.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wuran发布了新的文献求助30
3秒前
CipherSage应助wuran采纳,获得10
10秒前
17秒前
18秒前
23秒前
33秒前
moon发布了新的文献求助10
35秒前
科研通AI2S应助读书的时候采纳,获得10
35秒前
wuran发布了新的文献求助10
37秒前
CipherSage应助moon采纳,获得10
39秒前
所所应助wuran采纳,获得10
43秒前
59秒前
wuran发布了新的文献求助10
1分钟前
1分钟前
LH完成签到,获得积分10
1分钟前
大壮发布了新的文献求助10
2分钟前
小二郎应助读书的时候采纳,获得10
2分钟前
Alicia完成签到 ,获得积分10
2分钟前
科研通AI2S应助读书的时候采纳,获得10
2分钟前
wuran发布了新的文献求助10
2分钟前
万能图书馆应助wuran采纳,获得10
2分钟前
星辰大海应助读书的时候采纳,获得10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
上官若男应助读书的时候采纳,获得10
3分钟前
3分钟前
wuran发布了新的文献求助10
3分钟前
田様应助读书的时候采纳,获得10
3分钟前
Eeeee完成签到,获得积分10
3分钟前
wuran发布了新的文献求助10
3分钟前
Owen应助读书的时候采纳,获得10
3分钟前
4分钟前
乐乐应助读书的时候采纳,获得10
4分钟前
田様应助执着的忆雪采纳,获得10
4分钟前
MA发布了新的文献求助10
4分钟前
4分钟前
MA完成签到,获得积分10
4分钟前
FashionBoy应助读书的时候采纳,获得10
4分钟前
我是老大应助wuran采纳,获得10
4分钟前
5分钟前
1044完成签到 ,获得积分10
5分钟前
高分求助中
Semantics for Latin: An Introduction 1055
Plutonium Handbook 1000
Three plays : drama 1000
International Code of Nomenclature for algae, fungi, and plants (Madrid Code) (Regnum Vegetabile) 1000
Psychology Applied to Teaching 14th Edition 600
Robot-supported joining of reinforcement textiles with one-sided sewing heads 600
Apiaceae Himalayenses. 2 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4099074
求助须知:如何正确求助?哪些是违规求助? 3636635
关于积分的说明 11525682
捐赠科研通 3346398
什么是DOI,文献DOI怎么找? 1839241
邀请新用户注册赠送积分活动 906499
科研通“疑难数据库(出版商)”最低求助积分说明 823819